157 related articles for article (PubMed ID: 12094474)
1. Acute myeloid leukemia and related conditions.
Todd WM
Hematol Oncol Clin North Am; 2002 Apr; 16(2):301-19. PubMed ID: 12094474
[TBL] [Abstract][Full Text] [Related]
2. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
3. Myelomastocytic overlap syndromes: biology, criteria, and relationship to mastocytosis.
Valent P; Sperr WR; Samorapoompichit P; Geissler K; Lechner K; Horny HP; Bennett JM
Leuk Res; 2001 Jul; 25(7):595-602. PubMed ID: 11377685
[TBL] [Abstract][Full Text] [Related]
4. Myeloid malignancies: myelodysplastic syndromes, myeloproliferative disorders, and acute myeloid leukemia.
Wood BL
Clin Lab Med; 2007 Sep; 27(3):551-75, vii. PubMed ID: 17658407
[TBL] [Abstract][Full Text] [Related]
5. Quantitation of minimal residual disease in acute myelogenous leukemia and myelodysplastic syndromes in complete remission by molecular cytogenetics of progenitor cells.
Engel H; Drach J; Keyhani A; Jiang S; Van NT; Kimmel M; Sanchez-Williams G; Goodacre A; Andreeff M
Leukemia; 1999 Apr; 13(4):568-77. PubMed ID: 10214863
[TBL] [Abstract][Full Text] [Related]
6. Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies. Working Group on Flow Cytometry and Image Analysis.
Rothe G; Schmitz G
Leukemia; 1996 May; 10(5):877-95. PubMed ID: 8656686
[TBL] [Abstract][Full Text] [Related]
7. Discordant expression of AC133 and AC141 in patients with myelodysplastic syndrome (MDS) and acute myelogeneous leukemia (AML).
Green CL; Loken M; Buck D; Deeg HJ
Leukemia; 2000 Apr; 14(4):770-2. PubMed ID: 10764169
[No Abstract] [Full Text] [Related]
8. Expression of the hemoglobin scavenger receptor (CD163/HbSR) as immunophenotypic marker of monocytic lineage in acute myeloid leukemia.
Walter RB; Bächli EB; Schaer DJ; Rüegg R; Schoedon G
Blood; 2003 May; 101(9):3755-6. PubMed ID: 12707228
[No Abstract] [Full Text] [Related]
9. Immunophenotypic analysis of acute lymphocytic leukemia.
Riley RS; Massey D; Jackson-Cook C; Idowu M; Romagnoli G
Hematol Oncol Clin North Am; 2002 Apr; 16(2):245-99, v. PubMed ID: 12094473
[TBL] [Abstract][Full Text] [Related]
10. Clinical applications of molecular haematology: flow cytometry in leukaemias and myelodysplastic syndromes.
Dalal BI
J Assoc Physicians India; 2007 Aug; 55():571-3. PubMed ID: 18019799
[TBL] [Abstract][Full Text] [Related]
11. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.
Arber DA; Orazi A; Hasserjian R; Thiele J; Borowitz MJ; Le Beau MM; Bloomfield CD; Cazzola M; Vardiman JW
Blood; 2016 May; 127(20):2391-405. PubMed ID: 27069254
[TBL] [Abstract][Full Text] [Related]
12. Multiparameter flow cytometry reveals myelodysplasia-related aberrant antigen expression in myelodysplastic/myeloproliferative neoplasms.
Kern W; Bacher U; Schnittger S; Alpermann T; Haferlach C; Haferlach T
Cytometry B Clin Cytom; 2013 May; 84(3):194-7. PubMed ID: 23283847
[TBL] [Abstract][Full Text] [Related]
13. Detection of residual disease in pediatric B-cell precursor acute lymphoblastic leukemia by comparative phenotype mapping: method and significance.
Dworzak MN; Fritsch G; Panzer-Grümayer ER; Mann G; Gadner H
Leuk Lymphoma; 2000 Jul; 38(3-4):295-308. PubMed ID: 10830736
[TBL] [Abstract][Full Text] [Related]
14. Immunophenotypes in adult acute lymphocytic leukemia. Role of flow cytometry in diagnosis and monitoring of disease.
Huh YO; Ibrahim S
Hematol Oncol Clin North Am; 2000 Dec; 14(6):1251-65. PubMed ID: 11147222
[TBL] [Abstract][Full Text] [Related]
15. Review of the relevance of aberrant antigen expression by flow cytometry in myeloid neoplasms.
Ossenkoppele GJ; van de Loosdrecht AA; Schuurhuis GJ
Br J Haematol; 2011 May; 153(4):421-36. PubMed ID: 21385170
[TBL] [Abstract][Full Text] [Related]
16. Using 4-color flow cytometry to identify abnormal myeloid populations.
Kussick SJ; Wood BL
Arch Pathol Lab Med; 2003 Sep; 127(9):1140-7. PubMed ID: 12946231
[TBL] [Abstract][Full Text] [Related]
17. [Panmyelopathy and myeloproliferative syndrome].
Jorke D; Bach G
Z Gesamte Inn Med; 1986 Nov; 41(21):595-8. PubMed ID: 3469815
[TBL] [Abstract][Full Text] [Related]
18. Screening bone marrow samples for abnormal lymphoid populations and myelodysplasia-related features with one 10-color 14-antibody screening tube.
Rajab A; Porwit A
Cytometry B Clin Cytom; 2015; 88(4):253-60. PubMed ID: 25664445
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis of myeloid hematologic malignancies: contributions of the 2001 World Health Organization (WHO) classification].
Leymarie V; Galoisy AC; Falkenrodt A; Lessard M
Ann Biol Clin (Paris); 2004; 62(5):513-20. PubMed ID: 15355801
[TBL] [Abstract][Full Text] [Related]
20. Definition of acute biphenotypic leukemia.
Matutes E; Morilla R; Farahat N; Carbonell F; Swansbury J; Dyer M; Catovsky D
Haematologica; 1997; 82(1):64-6. PubMed ID: 9107085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
